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Objective: To investigate the effects of the leaf ethanolic extract of Pseuderanthemum
palatiferum (PPE) and its isolated phytochemicals, stigmasterol and sitosterol-3-O-b-D-
glucopyranoside, against a-amylase and a-glucosidase enzyme activities both in vitro and
in vivo.
Methods: A concentration of maltose, which is a product released in a-amylase-cata-
lyzing reaction, was used as an index of in vitro a-amylase activity. Meanwhile, in vitro
a-glucosidase enzyme activity was indicated by the amount of liberated p-nitrophenol in
a-glucosidase-catalyzing reaction. In vivo a-amylase and a-glucosidase enzyme activities
were evaluated in the normal rats by using oral starch tolerance test and oral sucrose
tolerance test, respectively.
Results: PPE exerted a concentration-dependent inhibitory action against both a-
amylase and a-glucosidase in vitro with the IC50 values of (11.79 ± 8.10) mg/mL and
(1.00 ± 0.11) mg/mL, respectively. Stigmasterol and sitosterol-3-O-b-D-glucopyranoside
also exerted an in vitro a-amylase inhibition with the IC50 values of (59.41 ± 8.22) mg/mL
and (111.19 ± 9.02) mg/mL, respectively. However, these phytochemicals did not produce
a concentration-dependent inhibition against in vitro a-glucosidase activity. PPE and its
isolated phytochemicals signiﬁcantly decreased the blood glucose levels at t = 30 min in
the oral starch tolerance test. From the sucrose tolerance test, only PPE but not its isolated
phytochemicals signiﬁcantly caused a depletion in the blood glucose levels at t = 30 min
Conclusions: These results indicate an inhibitory action against carbohydrate-digesting
enzymes as the anti-diabetic mechanism of action of PPE. Nonetheless, further clinical
study is required to justify its role in the treatment of diabetes.1. Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder,
characterized by an elevation of plasma glucose levels as a result
of dysfunctions in insulin secretion and/or insulin actions. A
prevalence of DM, especially type 2 DM, has continuously
raised with the estimated global prevalence of 9% among adults
in 2014 [1]. Chronic hyperglycemia evolved from diabetes
ultimately leads to a pathogenesis of chronic diabetic
complications especially cardiovascular disease, which is a
major leading cause of death in diabetic patients [1]. Inaddition to fasting plasma glucose, postprandial (after-meal)
plasma glucose plays a crucial role in the control of diabetes
and its complications. Postprandial hyperglycemia contributes
to a destruction of pancreatic b-cells and the developments of
both micro- and macro-vascular complications [2,3]. A level of
postprandial plasma glucose is mainly regulated by the
function of carbohydrate-digesting enzymes in the intestine
speciﬁcally a-amylase and a-glucosidase. Pancreatic a-amylase
enzyme catalyzes a breakdown of a(1–4) glycosidic bond of
starch, whilst intestinal a-glucosidase is essential for a digestion
of oligosaccharides and disaccharides [4]. These two enzymescy, Mahasarakham University, Maha Sarakham
ines for use and care of experimental animals (pro-
iversity, Thailand (Reference number: 009/2556).
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glucose levels.
Pseuderanthemum palatiferum (Nees) Radlk. (P. palatiferum)
has been used as a folk medicine for the treatment of diabetes in
several Southeast Asian countries. The fasting plasma glucose-
lowering effect of the plant's leaf ethanolic extract and its iso-
lated phytochemicals were evidenced in the streptozotocin-
induced diabetic rats [5,6]. Our previous study showed that the
leaf ethanolic extract of P. palatiferum (PPE) possessed anti-
lipolytic, antioxidant and in vitro a-amylase inhibitory activities
[7]. However, it is not known whether the extract exerts its
inhibitory action against carbohydrate-digesting enzymes
in vivo. Additionally, the plant extract-derived phytochemical
which acts as an enzyme inhibitor has not been documented yet.
The current study thus aimed to investigate the effects of PPE and
its major isolated phytochemicals against a-amylase and a-
glucosidase enzyme activities both in vitro and in vivo.
2. Materials and methods
2.1. Preparation of PPE extract
The leaves of P. palatiferum were collected from the plan-
tation in Roi Et Province, Thailand. The authentication of the
specimens was performed by the Plant Varieties Protection Di-
vision, Department of Agriculture, Ministry of Agriculture and
Cooperatives. A voucher is collected at the Herbarium of
Pharmaceutical Chemistry and Natural Product Research Unit,
the Faculty of Pharmacy, Mahasarakham University, Thailand
(code: MSU.PH-ACA-P1). The leaves were dried at 50 C for
45 h in a hot-air oven and subsequently macerated with 80%
ethanol in 1:10 ratio for 7 days. The extract was evaporated by
using a rotary evaporator (Heidolph Laborota 4000, Germany)
followed by a freeze dryer (Christ Alpha 1–4, Germany). PPE
with the yield (%) of 12.7% w/w was then achieved. The extract
was kept freezing at −20 C until use.
2.2. Isolation of the phytochemicals from PPE
Thin layer chromatography was conducted using normal-
phase silica gel 60 F254 (Merck, Germany) on precoated
aluminium plates. UV light (254 nm) and anisaldehyde-sulphuric
acid spray reagent were used for detection. Column chromatog-
raphy was carried out using silica gel 60 (0.063–0.200 mm;
Merck, Germany). The melting point was obtained by using a
Buchi melting point meter (Switzerland). UV spectra were ob-
tained from a JASCO V530 UV/Vis spectrophotometer (Japan),
while IR spectra were recorded with a Perkin Elmer Fourier
transform infrared spectroscopy spectrometer (Germany). The
mass spectra were obtained using a Bruker MicroTOF ESI-TOF
(USA) spectrometry double-focusing probe at 70 eV, while nu-
clear magnetic resonance (NMR) spectra (1D and 2D) were
measured on a Varian Mercury Plus 400 (USA) at 400 MHz for
1H NMR and 100 MHz for 13C NMR spectra. Solvents were of
analytical grade such as n-hexane (Lab-scan, Ireland), dichloro-
methane (CH2Cl2), ethyl acetate (EtOAc), methanol (MeOH)
(Carlo Erba, Italy), and ethanol (EtOH) (Merck, Germany).
The procedure was similar to that described previously [6].
Concisely, the PPE was suspended in 80% MeOH and partitioned
successively with n-hexane extract. The n-hexane extract was
chromatographed on a silica gel column and eluted with gradient
of n-hexane and EtOAc (100:0, 80:20, 70:30, 50:50, 30:70, 20:80and 0:100 v/v), each portion of 500 mL. These elutes were
collected in a series of test tubes with 20 mL in each fraction. The
homogeneity of the eluted was monitored by thin layer
chromatography and the identical fractions were combined to
afford ﬁve fractions. Fraction 1 was rechromatographed on a
silica gel column and eluted with n-hexane: EtOAc (8:2 v/v) to
afford stigmasterol. Fraction 5 was precipitated with EtOAc to
yield sitosterol-3-O-b-D-glucopyranoside.
2.3. In vitro study
2.3.1. a-Amylase enzyme activity assay
The a-amylase enzyme activity assay was performed ac-
cording to the method of Ali et al. with slight modiﬁcations [8].
Brieﬂy, a mixture of 200 mL of freshly prepared porcine
pancreatic a-amylase (4 unit/mL) and 40 mL of the sample
was prepared and incubated at 25 C for 5 min. Potato starch
solution (0.5% w/v, 400 mL) and distilled water (160 mL)
were subsequently added into the mixture and incubated at
25 C for further 3 min. A 200 mL volume of the mixture was
added into a new microfuge tube containing 100 mL of 3,5-
dinitrosalicylic acid color reagent solution (96 mmol/L 3,5-
dinitrosalicylic acid and 5.31 mol/L sodium potassium tartrate
in 2 mol/L NaOH) and then heated at 85 C for 15 min. The
optical density of the mixture was measured at the wavelength of
540 nm. The absorbance of the colored sample was subtracted
by the absorbance of the blank in order to obtain the exact
absorbance of the mixture. The amount of generated maltose,
calculated from the maltose standard curve, was used as an index
of a-amylase enzyme activity. Percent reaction was obtained
with the following equation: % Reaction=(Mean maltose in
sample/Mean maltose in negative control) × 100.
Percent inhibition was calculated as 100 - % reaction. The
concentration-inhibitory response curve was plotted by using
GraphPad Prism software version 6.0.
2.3.2. a-Glucosidase enzyme activity assay
The a-glucosidase enzyme activity was examined following
the protocol of Elya et al. with slightmodiﬁcations [9]. The reaction
mixture containing 10 mL of sample, 250 mL of p-nitrophenyl-a-D-
glucopyranoside (p-NPG; 5 mmol/L) and 490 mL of phosphate
buffer (100 mmol/L, pH 6.8) was prepared and incubated at
37 C for 5 min. A 250 mL volume of a-glucosidase enzyme
(0.15 unit/mL) was added into the mixture and then incubated
for further 15 min at 37 C. A 250 mL volume of the mixture
was then transferred into a new microfuge tube containing
500 mL of Na2CO3. The optical density (OD) of the mixture was
measured at the wavelength of 405 nm. The amount of p-
nitrophenol released from a-glucosidase-catalyzing reaction was
used as an index of a-glucosidase enzyme activity. The
percentage of inhibition was calculated as the following
equation: % Inhibition = [(OD of negative control)−(OD of
sample)/(OD of negative control)] × 100.
The concentration-inhibitory response curve was plotted by
using GraphPad Prism software version 6.0.
2.4. In vivo study
2.4.1. Experimental animals
Male Wistar rats weighing 150–170 g were obtained from the
National Laboratory Animal Center, Mahidol University,
Thailand and housed at a constant temperature of (25 ± 1) C
Table 1
The percentage of inhibition of PPE against a-amylase enzyme
activity. %.
PPE concentrations (mg/mL) Inhibition
0 0.00 ± 1.98
0.1 −16.37 ± 7.87
0.3 −22.64 ± 7.87
1 −0.69 ± 11.65
3 11.87 ± 12.86
10 49.34 ± 6.82*
20 88.87 ± 3.78*
30 8 9.79 ± 3.42*
Data are expressed as mean ± SD, n = 6. *: P < 0.05 when compared
with vehicle control (dimethyl sulfoxide). One-way ANOVA and Bon-
ferroni post-hoc test were used.
Table 2
Median inhibitory concentrations (IC50) of PPE and its phytochemicals
against a-amylase and a-glucosidase enzyme activities.
Enzyme activity Agents
PPE (mg/mL) Stigmasterol
(mg/mL)
Sitosterol-3-O-b-D-
glucopyranoside
(mg/mL)
a-Amylase 11.79 ± 8.10 59.41 ± 8.22 111.19 ± 9.02
a-Glucosidase 1.00 ± 0.11 n/d n/d
n/d: Not determined.
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free access to water. The oral carbohydrate tolerance test was
performed after 1-week acclimatization. All procedures with the
animals were approved by the Animal Research Ethics Com-
mittee, Mahasarakham University, Thailand (No. 009/2556).
2.4.2. Oral starch tolerance test
The rats were divided into nine groups (n = 5 per group) and
fasted overnight but had free access to water. Groups 1–3 were
treated orally with PPE at the doses of 250, 500 and 1000 mg/kg
body weight. Stigmasterol and sitosterol-3-O-b-D-glucopyrano-
side, isolated from PPE, were given to Groups 4–7 at the doses
of 5 and 10 mg/kg, respectively. Group 8 was treated with
acarbose (a positive control) at the dose of 10 mg/kg body
weight, whilst Group 9 was orally fed with 2% Tween 80 (a
vehicle control). After treatment with the designated agents for
10 min, all rats were orally given with starch (3 g/kg body
weight). The blood glucose levels were measured by using a
glucometer (Accu-Chek® Active, Roche Diagnostic, Thailand)
at before (t = 0) and at 30, 60 and 120 min after starch feeding.
2.4.3. Oral sucrose tolerance test
The rats were divided into nine groups (n = 5 per group) and
treated with the similar treatments as those in the oral starch
tolerance test. All rats were fed with sucrose (4 g/kg body
weight) solution at 10 min after the treatment. The blood glucose
levels were measured at before (t = 0) and at 30, 60 and 120 min
after sucrose feeding.
2.5. Statistical analysis
All data from the in vitro experiments were expressed as
mean ± SD, except the IC50 valueswere expressed asmean ± SEM.
The in vivo data were presented as mean ± SEM. The data were
statistically analyzed using One-way analysis of variance
(ANOVA) followed by the Bonferroni post-hoc test. Statistically
signiﬁcant differences were indicated by a P-value of <0.05.
3. Results
3.1. Isolation of stigmasterol and sitosterol-3-O-b-D-
glucopyranoside from PPE
Stigmasterol was obtained as white needle crystals, melting
point 135–136 C and its molecular formula was assigned to be
C29H48O according to it mass spectrum (m/z 412 [M]
+). Sitos-
terol-3-O-b-D-glucopyranoside was obtained as white needle
crystals, melting point 297–298 C and its molecular formula was
assigned to be C35H60O6 according to it mass spectrum (m/z 5995
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Figure 1. Kinetics analysis of a-amylase inhibition by (A) PPE and acarbos
glucopyranoside.
Data are expressed as mean ± SEM, n = 6. Lineweaver–Burk plot of the react[M+Na]+). The stigmasterol and sitosterol-3-O-b-D-glucopyrano-
side were identiﬁed by comparing their physical and spectro-
scopic data of IR, NMR and mass spectra with the reported in the
literature [6] and analyzing their 2D NMR spectral data.
3.2. Inhibitory effects of PPE against in vitro a-amylase
enzyme activity
PPE at the concentrations of 10, 20 and 30mg/mL signiﬁcantly
inhibited a-amylase enzyme activity (Table 1). The maximal in-hibition of (89.79 ± 3.42)% was found at the PPE concentration of
30 mg/mL (n = 6, P < 0.05). This is similar to the a-amylase
inhibitory effect of 100 mg/mL acarbose (85.12 ± 3.47)%. The PPE
extract produced a concentration-dependent inhibitory action
against a-amylase enzyme activity with an IC50 of (11.79 ± 8.10)
mg/mL (mean ± SEM, n = 6) (Table 2).The experiment on a-amylase enzyme kinetics was then
subsequently studied by varying substrate concentrations at
0.5%, 1%, 1.5% and 2% w/v with the ﬁxed PPE concentration of
10 mg/mL (approximate IC50). Lineweaver–Burk plot was
drawn to determine the enzyme kinetics in the presence and the
absence of PPE (Figure 1A). PPE (10 mg/mL) caused a decrease1.5
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e, (B) PPE-derived stigmasterol and (C) PPE-derived sitosterol-3-O-b-D-
ion against a-amylase in the presence or absence of the test agents.
Table 5
The percentage of inhibition of PPE-derived sitosterol-3-O-b-D-gluco-
pyranoside against a-amylase enzyme activity. %.
Pawitra Pulbutr et al./Asian Pac J Trop Biomed 2016; 6(2): 93–9996in maximal rate of reaction (Vmax) and an increase in Michaelis
constant (Km) (Table 3). This mode of changes in enzyme ki-
netics was similar to that caused by acarbose.Table 3
Changes of Vmax and Km of a-amylase enzyme in the presence of the test
agents.
Agents Vmax
(% w/v of maltose/min)
Km
(% w/v of starch)
PPE (10 mg/mL) −0.38 +0.88
Stigmasterol
(60 mg/mL)
−0.14 +0.81
Sitosterol-3-O-b-D-
glucopyranoside
(100 mg/mL)
−1.44 −0.28
Acarbose
(100 mg/mL)
−0.20 +1.18
Sitosterol-3-O-b-D-glucopyranoside
concentrations (mg/mL)
Inhibition
0 0.00 ± 1.98
3 1.36 ± 0.63
10 5.28 ± 1.34
30 8.67 ± 2.02
100 25.78 ± 2.11*
300 35.29 ± 1.46*
1000 47.53 ± 5.59*
3000 46.83 ± 1.51*
Data are expressed as mean ± SD, n = 3. *: P < 0.05 when compared
with vehicle control (dimethyl sulfoxide). One-way ANOVA and Bon-
ferroni post-hoc test were used.3.3. Inhibitory effects of PPE-derived stigmasterol
against in vitro a-amylase enzyme activity
Stigmasterol, isolated from PPE, at the concentrations of 300
and 1000 mg/mL signiﬁcantly inhibited a-amylase enzyme ac-
tivity with the maximal inhibition of (42.68 ± 3.69)% (n = 3)
achieved at the concentration of 1000 mg/mL (Table 4). IC50 ofTable 4
The percentage of inhibition of PPE-derived stigmasterol against
a-amylase enzyme activity. %.
Stigmasterol concentrations (mg/mL) Inhibition
0 0.00 ± 1.51
1 −9.86 ± 11.77
3 −0.71 ± 6.03
10 1.12 ± 4.34
30 15.22 ± 5.66
100 21.13 ± 4.61
300 39.80 ± 4.58*
1000 42.68 ± 3.69*
Data are expressed as mean ± SD, n = 3. *: P < 0.05 when compared
with vehicle control (dimethyl sulfoxide: Tween 80: Span 20 = 2:1:1);
One-way ANOVA and Bonferroni post-hoc test were used.
Table 6
The percentage of inhibition of PPE against a-glucosidase enzyme
activity. %.
PPE extract concentrations (mg/mL) Inhibition
0 0.00 ± 0.04
3 12.43 ± 1.84*
10 10.35 ± 1.12*
30 13.10 ± 1.67*
100 14.51 ± 1.26*
300 18.60 ± 1.29*
1000 37.90 ± 2.62*
3000 47.70 ± 2.13*
5000 42.83 ± 2.79*
Data are expressed as mean ± SD, n = 4. *: P < 0.05 when compared
with vehicle control (dimethyl sulfoxide). One-way ANOVA and Bon-
ferroni post-hoc test were used.(59.41 ± 8.22) mg/mL (mean ± SEM, n = 3) was obtained from a
concentration-inhibitory response curve of PPE-derived stig-
masterol (Table 2). Lineweaver–Burk plot was drawn from the
a-amylase enzyme kinetics study in the absence and the pres-
ence of 60 mg/mL stigmasterol (approximate IC50) (Figure 1B).
Stigmasterol produced changes in both Vmax and Km with a
decrease in Vmax and an increase in Km (Table 3).
3.4. Inhibitory effects of PPE-derived sitosterol-3-O-b-
D-glucopyranoside against in vitro a-amylase enzyme
activity
Sitosterol-3-O-b-D-glucopyranoside isolated from PPE at the
concentrations of 100, 300, 1000 and 3000 mg/mL produced a
signiﬁcant inhibitory action against a-amylase enzyme activity
(n = 3, P < 0.05) (Table 5). The maximal inhibitory action
(47.53 ± 5.59)% was found at the concentration of 1000 mg/mL.PPE-derived sitosterol-3-O-b-D-glucopyranoside produced a
concentration-dependent inhibition against a-amylase enzyme
with the IC50 of (111.19 ± 9.02) mg/mL (mean ± SEM, n = 3)
(Table 2). From the Lineweaver–Burk plot (Figure 1C), sitos-
terol-3-O-b-D-glucopyranoside isolated from PPE at the con-
centration of 100 mg/mL (estimated IC50) provoked a decrease in
both Vmax and Km (Table 3).
3.5. Inhibitory effects of PPE against in vitro
a-glucosidase enzyme activity
PPE at every concentration tested produced a signiﬁcant
inhibitory action against a-glucosidase enzyme activity with a
maximal inhibition of (47.70 ± 2.13)% reached at the concen-
tration of 3000 mg/mL (Table 6). A similar degree of inhibitionof (43.86 ± 1.97)% was found with 200 mg/mL of acarbose.
Median inhibitory concentration of (1.00 ± 0.11) mg/mL
(mean ± SEM, n = 4) was obtained from the concentration-
inhibitory response curve of PPE (Table 2).
a-Glucosidase enzyme kinetics study was performed with
various concentrations of p-NPG (0.037 5, 0.075, 0.15 and
0.30 IU/mL) in the presence or the absence of 1 mg/mL PPE
(approximate IC50). From the Lineweaver–Burk plot, PPE
caused a decrease in Vmax without any change in Km. On the
contrary, acarbose induced changes in both Vmax and Km, with a
decrease in Vmax and an increase in Km (Table 7 and Figure 2).
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Figure 3. Effects of PPE (A) and its isolated phytochemicals (B) on oral
starch tolerance test.
The levels of blood glucose at t = 0, 30, 60 and 120 min after oral starch
feeding were expressed as mean ± SEM (n = 5). aP < 0.05 when compared
to vehicle control at t = 30 min; bP < 0.05 when compared to vehicle
control at t = 60 min.
Table 7
Changes of Vmax and Km of a-glucosidase enzyme in the presence of the
test agents.
Agents DVmax
(unit of p-nitrophenol/min)
DKm (unit/mL of p-NPG)
PPE −0.27 0
Acarbose −0.09 +0.10
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Figure 2. Kinetics analysis of a-glucosidase inhibition by PPE.
Data are expressed as mean ± SEM, n = 6. Lineweaver–Burk plot of the
reaction against a-glucosidase in the presence of PPE (1 mg/mL) or acar-
bose (200 mg/mL).
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against in vitro a-glucosidase enzyme activity
Stigmasterol and sitosterol-3-O-b-D-glucopyranoside, iso-
lated from PPE, produced a concentration-independent inhibi-
tion against a-glucosidase enzyme activity with a small
inhibition of approximately 10% found at the concentrations of
0.1 and 1 mg/mL (Table 8).Table 8
The percentage of inhibition of PPE-derived stigmasterol and sitosterol-
3-O-b-D-glucopyranoside against a-glucosidase enzyme activity. %.
Concentrations
(mg/mL)
Inhibition
Stigmasterol Sitosterol-3-O-b-D-glucopyranoside
0.1 12.42 ± 1.52* 13.84 ± 3.24*
1 10.22 ± 1.81* 14.04 ± 1.85*
10 5.47 ± 1.84 12.79 ± 0.52*
100 6.05 ± 0.93 8.68 ± 0.95
1000 −4.37 ± 4.01 7.11 ± 3.55
Data are expressed as mean ± SD, n = 6. *: P < 0.05 when compared
with vehicle control (dimethyl sulfoxide). One-way ANOVA and Bon-
ferroni post-hoc test were used.
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Figure 4. Effects of PPE (A) and its isolated phytochemicals (B) on oral
sucrose tolerance test.
The levels of blood glucose at t = 0, 30, 60 and 120 min after oral starch
feeding were expressed as mean ± SEM (n = 5). aP < 0.05 when compared
to vehicle control at t = 30 min.3.7. Oral starch tolerance test
When PPE at the doses of 250, 500 and 1000 mg/kg body
weight were given to the rats prior to oral starch feeding, a
signiﬁcant decrease in the blood glucose concentrations was
found at 30 min after oral starch feeding (3 g/kg body weight)
(Figure 3A). PPE at the doses of 250 and 1000 mg/kg body
weight also signiﬁcantly decreased the blood glucose levels at
60 min after oral starch feeding. However, PPE at any doses
tested did not cause any signiﬁcant change at 120 min after oral
starch feeding. Stigmasterol and sitosterol-3-O-b-D-glucopyr-
anoside, isolated from PPE, at the doses of 5 and 10 mg/kg also
caused a signiﬁcant decrease in blood glucose at t = 30 min(Figure 3B). However, these two phytochemicals did not affect
the blood glucose levels at 60 and 120 min after oral starch
feeding. Acarbose (a positive control) at the dose of 10 mg/kg
body weight caused a signiﬁcant decrease in the blood glucose at
30 and 60 min after oral starch feeding (Figure 3). Acarbose did
not cause a signiﬁcant reduction in the blood glucose levels at
t = 120 min.
3.8. Oral sucrose tolerance test
Treatment with either 250 mg/kg body weight PPE or 10 mg/
kg body weight acarbose before oral sucrose feeding (4 g/kg
body weight) signiﬁcantly decreased the blood glucose levels at
t = 30 min (Figure 4A). However, these treatments did not affect
Pawitra Pulbutr et al./Asian Pac J Trop Biomed 2016; 6(2): 93–9998the blood glucose levels at both t = 60 min and t = 120 min.
Other treatments (500 and 1000 mg/kg body weight of PPE; 5
and 10 mg/kg body weight of stigmasterol; 5 and 10 mg/kg body
weight of sitosterol-3-O-b-D-glucopyranoside) did not cause any
signiﬁcant decrease in the oral sucrose tolerance test (Figure 4).
4. Discussion
4.1. Inhibitory effects of PPE and its phytochemicals
against in vitro and in vivo a-amylase enzyme activity
PPE exhibited a concentration-dependent inhibitory action
against in vitro a-amylase enzyme activity with an IC50 of
(11.79 ± 8.10) mg/mL (mean ± SEM, n = 6). The maximal
inhibitory action of (89.79 ± 3.42)% was found at the concen-
tration of 30 mg/mL. This is in accordance with our previous
preliminary study in which a single IC50 of 5 mg/mL was re-
ported [7]. The experiment on a-amylase enzyme kinetics
showed that PPE (10 mg/mL) caused a decrease in Vmax and
an increase in Km. Thus, PPE inhibited a-amylase enzyme in
a mixed inhibition manner. This suggests that PPE can bind to
either enzyme or enzyme–substrate complex to form enzyme-
PPE complex or enzyme-substrate-PPE complex, respectively.
Following these complex formations, a-amylase enzyme is thus
no longer available for catalyzing starch digestion. This mode of
enzyme inhibition is similar to that of acarbose (Figure 1A). A
mixed inhibitory action of acarbose against a-amylase was also
reported by Al Kazaz et al. [10] and Desseaux et al. [11]. It should
be noted that 10 mg/mL PPE (approximate IC50) and 100 mg/mL
acarbose produced changes in both Vmax and Km at the
comparable degrees (Table 3).
Stigmasterol derived from PPE possessed a concentration-
dependent inhibitory action against a-amylase enzyme with
the IC50 of (59.41 ± 8.22) mg/mL (mean ± SEM, n = 3). The
maximal inhibition of (42.68 ± 3.69)% (n = 3) was achieved at
the concentration of 1000 mg/mL. Stigmasterol isolated from
leaves of Dillenia indica (D. indica) at the concentration of
50 mg/mL inhibited a-amylase enzyme activity by 48% [12].
From the study of Kumar et al. [12], starch azure was used
as a substrate and a-amylase enzyme activity was indicated
by the levels of its released product, Remazol Brilliant
Blue R. The difference in methods used may partly
explain the discrepancy of stigmasterol potency found
between studies.
Sitosterol-3-O-b-D-glucopyranoside isolated from PPE
possessed a concentration-dependent inhibitory action against
in vitro a-amylase enzyme activity with an IC50 of
(111.19 ± 9.02) mg/mL (mean ± SEM, n = 3). Nkobole et al.
reported a slightly more potent a-amylase inhibitory action of
b-sitosterol isolated from Terminalia sericea bark, with the
IC50 of 216 mmol/L (89.57 mg/mL) [13]. It was also shown that
b-sitosterol derived from leaves of D. indica at the
concentration of 50 mg/mL inhibited a-amylase enzyme
activity by 45% [12]. However, sitosterol-3-O-b-D-glucopyr-
anoside at the concentration of 30 mg/mL exhibited a relatively
low level of enzyme inhibition (8.67 ± 2.02)% in this study.
These thus suggest that a sugar moiety presented in the
chemical structure of isolated sitosterol-3-O-b-D-glucopyrano-
side possibly impedes its inhibitory action against a-amylase
enzyme.
The results from enzyme kinetics study indicated that stig-
masterol exhibited its inhibitory action against a-amylase in amixed inhibition manner, whilst sitosterol-3-O-b-D-glucopyr-
anoside exerted its enzyme inhibition in an uncompetitive
fashion. Since PPE demonstrated a mixed inhibitory action
against a-amylase enzyme, stigmasterol is thus likely to be a
primary phytochemical which plays a role in the a-amylase
inhibitory action of PPE. Nonetheless, further experiment should
be done to explore whether these phytochemicals can produce
either synergistic or antagonistic effect when they coexist. A
mixed inhibitory mode of action of PPE proposes its advantage
in the clinical use. A decrease in Vmax implies that the maximal
rate of reaction would be lessened, regardless to the amount of
ingested starch. Additionally, an increase in Km suggests that a
substantially lower rate of reaction arises if a similar amount of
starch is consumed.
The oral starch tolerance test is essential to prove whether
the agents provoke a certain a-amylase inhibitory action
in vivo. PPE (250, 500 and 1000 mg/kg body weight) and its
two isolated phytochemicals (stigmasterol and sitosterol-3-O-
b-D-glucopyranoside, at 5 and 10 mg/kg body weight) caused a
signiﬁcant decrease in the blood glucose levels at t = 30 min.
Thus, the inhibitory action of PPE against starch digestion
in vivo potentially arises from the actions of these two phyto-
chemicals. At t = 60 min, PPE at the doses of 250 and
1000 mg/kg body weight signiﬁcantly decreased the blood
glucose levels. However, neither stigmasterol nor sitosterol-3-
O-b-D-glucopyranoside lowered the blood glucose levels at
t = 60 min. It is possible that the given doses of these two
phytochemicals were not sufﬁcient to inhibit in vivo a-amylase
enzyme activity at t = 60 min, when an adaptive increase of a-
amylase enzyme secretion may develop in vivo. PPE and its
phytochemicals did not produce a substantial change in the
blood glucose level at t = 120 min. This suggests that PPE
exerted its action in a reversible manner, which may reduce a
risk of adverse drug reactions caused by an indigested carbo-
hydrate in the intestine. Acarbose also showed the blood
glucose-lowering action only at t = 30 min and t = 60 min.
Thus, both PPE and acarbose exhibited their blood glucose-
lowering action at a similar period of time. To our knowl-
edge, this is the ﬁrst report of the in vivo a-amylase inhibitory
action of PPE and its isolated phytochemicals.
4.2. Inhibitory effects of PPE and its phytochemicals
against in vitro and in vivo a-glucosidase enzyme
activity
PPE signiﬁcantly inhibited in vitro a-glucosidase enzyme
activity with the maximal inhibition of (47.70 ± 2.13)% and the
IC50 of (1.00 ± 0.11) mg/mL. The methanolic extract of
P. palatiferum leaves (1 mg/mL) was reported to have a slight a-
glucosidase inhibitory action of 7% [14]. This is different from
our results in which 1 mg/mL of PPE exhibited a considerable
a-glucosidase inhibition of approximately 40%. The difference
in the solvent used in the preparation of the extract may partly
be the reason for this discrepancy. Enzyme kinetics study
revealed that PPE exhibited a non-competitive inhibition
against a-glucosidase enzyme, whilst acarbose inhibited the
enzyme in a mixed inhibition manner.
Stigmasterol and sitosterol-3-O-b-D-glucopyranoside extrac-
ted from PPE possessed a weak and non-concentration-
dependent a-glucosidase inhibition. Stigmasterol and b-sitos-
terol (50 mg/mL) isolated from D. indica leaves was shown to
inhibit a-glucosidase enzyme by 34.2% and 52.5%, respectively
Pawitra Pulbutr et al./Asian Pac J Trop Biomed 2016; 6(2): 93–99 99[12]. The differences between the studies cannot be justiﬁed yet.
However, a puriﬁcation process of the isolated phytochemicals
may be involved.
From the oral sucrose tolerance test, PPE only at the dose of
250 mg/kg caused a signiﬁcant depletion of the blood glucose at
t = 30 min. However, neither stigmasterol nor sitosterol-3-O-b-
D-glucopyranoside at the tested doses caused a signiﬁcant
decrease in the blood glucose at any time examined. It is
possible that other unknown phytochemicals may be responsible
for the in vivo a-glucosidase inhibition of PPE. The other phy-
tochemicals found in the PPE include ﬂavonoids and its de-
rivatives such as kaempferol-3-methyl ether-7-O-b-glucoside
and apigenin-7-O-b-glucoside [15]. Both kaempferol and
apigenin were shown to have in vitro a-glucosidase inhibitory
action [16]. Nonetheless, it cannot be excluded that the doses
of phytochemicals used in this study are possibly insufﬁcient
to inhibit the enzyme activity in vivo.
PPE and its phytochemicals were shown to decrease the fasting
plasma glucose levels in the diabetic rats [5,6]. However, their
mechanism of anti-diabetic action has not been established.
Recently, anti-lipolytic and antioxidant activities of PPE were
described to be linked with its anti-diabetic efﬁcacy [7]. The
in vitro and in vivo a-amylase and a-glucosidase inhibitions of
PPE addressed herein further steadily explain its mechanism of
anti-diabetic action. The current in vitro and in vivo experiments
suggest that stigmasterol and sitosterol-3-O-b-D-glucopyranoside
are likely to be the active phytochemicals acting as a-amylase
enzyme inhibitors. However, the inhibitory action of these iso-
lated phytochemicals against a-glucosidase enzyme is scanty.
Postprandial hyperglycemia is implicated in chronic diabetic
complications and pancreatic beta-cell destruction [2,17,18]. A
restriction of intestinal carbohydrate digestion thus likely
conduces to a better control of diabetes. Both a-amylase and a-
glucosidase enzymes play a crucial role in an intestinal digestion
of complex carbohydrate, which is commonly found in a diet.
The dual inhibitory actions of PPE against these enzymes suggest
its advantage over a sole inhibition on each enzyme alone.
Although the current in vitro and in vivo experiments suggest the
potential therapeutic beneﬁt of PPE, further clinical study is still
required to conﬁrm its efﬁcacy and safety.
In conclusion, PPE and its isolated phytochemicals, stig-
masterol and sitosterol-3-O-b-D-glucopyranoside signiﬁcantly
inhibited both in vitro and in vivo a-amylase enzyme activity.
PPE also produced an appreciable inhibitory action against a-
glucosidase enzyme both in vitro and in vivo. However, the two
extracted phytochemicals are unlikely to act as an active com-
pound against a-glucosidase enzyme. These results thus provide
a scientiﬁc support for a traditional use of P. palatiferum leaves
in the treatment of diabetes. Nonetheless, further clinical study is
necessary to verify its role in the clinical management of
diabetes.
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